Optical coherence tomography angiography (OCTA) ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 13 | Multiple sclerosis/Neuromyelitis optica | 1 |
13. Multiple sclerosis/Neuromyelitis optica
Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03401879 (ClinicalTrials.gov) | February 1, 2018 | 10/1/2018 | Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis | Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting;Optic Neuritis | Device: Dynamic Vessel Analyzer (DVA);Device: Fourier Domain Doppler Optical Coherence Tomography (FDOCT);Device: Optical coherence tomography (OCT);Device: Optical coherence tomography angiography (OCTA) | Medical University of Vienna | NULL | Recruiting | 18 Years | N/A | All | 50 | N/A | Austria |